Nature’s Sunshine Products reported disappointing third quarter 2026 results, with revenue and earnings falling significantly below analyst projections. The performance was pressured by operational disruptions in China and slowing momentum in the digital segment, leading management to lower its full-year 2026 financial outlook.
Key Highlights
- Net sales decreased 9% to $116.6 million, missing the $129.5 million estimate due to a 14.9% decline in the Asia segment.
- GAAP diluted EPS fell to $0.11 from $0.30 in the year-ago period, failing to meet the $0.27 expectation.
- Full-year 2026 revenue guidance was revised downward to a range of $460 million to $470 million, compared to the previous outlook of $490 million to $500 million.
- Adjusted EBITDA guidance for the full year was cut to $44 million to $48 million from the prior $48 million to $52 million range.